BALAXI PHARMACEUTICALS LIMITED — Others, 25-08-2025: Shareholders meeting

Balaxi Pharmaceuticals held its 82nd Annual General Meeting. Shareholders reviewed and voted on key items, including adopting audited standalone and consolidated financial statements, re-appointing Mrs. Minoshi Maheshwari as a director, and appointing Secretarial Auditors. The Statutory Auditors' Report had no qualifications. The Secretarial Audit Report mentioned a Rs. 1.35 lakh penalty paid to NSE for a delay in appointing a woman independent director, noting no other material adverse effects. This meeting provided an opportunity for shareholders to engage and cast votes on company governance matters.